Skip to main content

Table 3 Values on measures amongst participants in the pilot randomised controlled phase at each time point

From: Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial

Outcome Baseline 3 weeks 12 weeks/3 months
Feedback No Feedback Feedback No feedback Feedback No feedback
M (SD) Median (range) M (SD) Median (range) M (SD) Median (range) M (SD) Median (range) M (SD) Median (range) M (SD) Median (range)
Performance-based
 Grip strength (Kg)
  Right 21 (13.2)   24 (13.1)   20 (13.7)   25 (13.6)      
  Left 19 (11.7)   17 (11.2)   23 (9.3)   15 (10.1)      
 10-m walk test (s) 43 (31.8)   40 (32.3)   37 (34.5)   48 (41.8)      
 MoCA 17 (5.6) 18 (9–28) 17 (6.4) 21 (7–26) 19 (7.4) 22 (6–28) 18 (6.4) 21 (7–26)     
 BI 9 (4.0) 8 (5–18) 11 (4.2) 11 (5–21) 12 (3.7) 12 (6–19) 12 (4.4) 13 (7–20)     
Self-report
 FSS   39 (9–50)   48 (9–60)   40 (33–55)   52 (20–63)     
 VAF-S   6 (0–10)   8 (0–10)   5 (3–10)   7 (5–10)     
 EQ-5D-5L VAS 47.9 (24.9) 52 (10–90) 55 (29.6) 60 (0–100) 52 (24.5) 57 (0–80) 61 (26.0) 70 (20–100) 55 (24.2) 50 (30–90) 60 (10.2) 60 (50–75)
 RMI   4 (1–13)   6 (2–15)   8 (1–14)   6 (3–15)   8 (3–15)   9 (0–14)
 WHODAS   48 (12–85)   54 (16–87)   46 (4–79)   44 (20–95)   39 (2–60)   45 (4–79)
  1. Data were included only if the patient successfully completed assessment.
  2. Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item); M, mean; SD, standard deviation. WHODAS scores represent a percentage of the maximum disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)